Chiu Laura S, Huang Kevin Z, Xu Xixi, Heeren Timothy, Haque Rubiya, Schroy Paul S
Department of Medicine, Section of Gastroenterology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA.
Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA.
J Clin Gastroenterol. 2024 Feb 1;58(2):162-168. doi: 10.1097/MCG.0000000000001840.
Non-Hispanic Black (NHB) patients with early-onset colorectal cancer (EOCRC) are more likely to present with advanced-stage disease than their Non-Hispanic White (NHW) counterparts. To further elucidate whether differences in tumor biology or disparities in access to care may be responsible, we examined the association between race/ethnicity and initial stage of disease, time to diagnosis, and tumor characteristics among NHW and NHB patients with EOCRC cared for in a safety-net health care setting.
We performed a retrospective cohort study of NHW and NHB patients diagnosed with primary EOCRC who received care at Boston Medical Center between January 2000 and May 2020. We compared demographics, risk factors, presenting signs/symptoms, time to diagnosis, health care utilization, and tumor characteristics (stage, grade, location, and mutational status).
We identified 103 patients (mean age 41.5±7.2 y, 53.4% men), including 40 NHWs and 63 NHBs, with EOCRC. NHB and NHW patients were similar with respect to demographics, presenting signs/symptoms, and risk factor distribution. There were also no significant differences between NHWs and NHBs with respect to the advanced stage of disease at presentation (45.0% vs. 42.9%, P =0.83), the median time to diagnosis [152 d (IQR, 40 to 341) vs. 160 d (IQR, 61 to 312), P =0.79] or tumor characteristics, except for a predilection for proximal disease among NHBs (30.2% vs. 15.0%).
NHB patients were no more likely than NHW patients to present with advanced-stage disease, aggressive tumor histology, or experience delays in diagnosis within a safety-net health care system.
与非西班牙裔白人(NHW)患者相比,患有早发性结直肠癌(EOCRC)的非西班牙裔黑人(NHB)患者更有可能出现晚期疾病。为了进一步阐明肿瘤生物学差异或就医机会不平等是否可能是原因所在,我们研究了在安全网医疗环境中接受治疗的NHW和NHB EOCRC患者的种族/民族与疾病初始阶段、诊断时间和肿瘤特征之间的关联。
我们对2000年1月至2020年5月期间在波士顿医疗中心接受治疗的诊断为原发性EOCRC的NHW和NHB患者进行了一项回顾性队列研究。我们比较了人口统计学、危险因素、出现的体征/症状、诊断时间、医疗保健利用情况和肿瘤特征(分期、分级、位置和突变状态)。
我们确定了103例EOCRC患者(平均年龄41.5±7.2岁,53.4%为男性),其中包括40例NHW患者和63例NHB患者。NHB和NHW患者在人口统计学、出现的体征/症状和危险因素分布方面相似。在就诊时疾病的晚期阶段(45.0%对42.9%,P =0.83)、诊断的中位时间[152天(四分位间距,40至341)对160天(四分位间距,61至312),P =0.79]或肿瘤特征方面,NHW和NHB患者之间也没有显著差异,只是NHB患者更倾向于近端疾病(30.2%对15.0%)。
在安全网医疗系统中,NHB患者出现晚期疾病、侵袭性肿瘤组织学或诊断延迟的可能性并不比NHW患者更高。